Flexible Approaches for Biotech Companies in Clinical Trials
With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech companies in clinical trials are different from...Risk Management for Biotech Companies in Clinical Trials
In this episode, the second of a three-part series, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage...3 Things to Consider in Preparation for Your Biotech Testing or Trial
In this podcast, the first of a three-part series, Alex Watt (Global Head for Biotech Integrated Laboratory Solutions at Q2 Solutions) talks about how biotech companies can best prepare for...
Barry Jones, Ph.D.
Hybrid assays: an interview with Barry Jones and Adriane Spytko
In this podcast Barry Jones (Director, LC–MS Biologics and Biomarkers at Q² Solutions) and Adriane Spytko (Manager, LC–MS Biologics at Q² Solutions; both NY, USA) discuss hybrid assays using both...